SERVICE
體 重 管 理
體重管理神隊友|油切小藍筆
兩個成人一個胖 別讓肥肉太囂張
兩個成人一個胖 別讓肥肉太囂張
美食當前總是克制不了食慾和飢餓感嗎?最新通過台灣衛福部核准的Saxenda®善纖達,經美國FDA以及歐洲EMA藥物管理局認證,能讓人產生飽足感、抑制食慾,進而達到體重控制的效果,並降低糖尿病、腦中風、心肌梗塞等肥胖併發症的發病率,是擁抱健康自信,提升生活品質的秘密武器。
Is food always unable to restrain appetite and hunger? The latest Saxenda® approved by the Taiwan Ministry of Health and Welfare, certified by the US FDA and the European EMA Drug Administration, can make people feel full, suppress appetite, and then achieve the effect of weight control , and reduce the incidence of obesity complications such as diabetes, stroke, myocardial infarction, etc., it is the secret weapon to embrace healthy self-confidence and improve the quality of life.
肥胖,是一種複雜的多因子疾病,不只會造成心血管疾病、糖尿病…等慢性疾病,也是現代人的罹癌風險因子之一。包括世界肥胖聯盟(WOF)、肥胖學會(TOS)、歐洲肥胖研究協會(EASO)…等醫療專業協會,都將肥胖視為需要「慢性病治療模式」的全球健康挑戰。因此減重、變瘦,不單單只是追求好看身型的表淺問題,避免肥胖而引起其他併發症,才是現代人的一大隱憂。
Obesity is a complex multifactorial disease that not only causes chronic diseases such as cardiovascular disease and diabetes, but is also one of the risk factors for cancer in modern people. Medical professional associations, including the World Obesity Federation (WOF), recognize obesity as a global health challenge that requires a “chronic disease treatment model.” Therefore, weight loss and thinning are not only a superficial problem of pursuing a good-looking body shape, but avoiding other complications caused by obesity is a major hidden worry for modern people.
肥胖症與超過195種併發症有關,其中「心血管疾病」是肥胖者的主要死因,且在美國確診癌症的案例中,就超過40%與過重有關!2021年5月台灣疫情升溫,中央流行疫情指揮中心曾公布1名30多歲年輕女性的本土個案病逝消息,發言人表示,該案體重約90幾公斤,肥胖很可能就是影響病況的風險因素之一。
Obesity is related to more than 195 complications, among which “cardiovascular disease” is the main cause of death for obese people, and in the cases of cancer diagnosed in the United States, more than 40% are related to overweight! In May 2021, the epidemic in Taiwan heated up. The Central Epidemic Command Center announced the death of a local case of a young woman in her 30s. The spokesperson said that the case weighed about 90 kilograms, and obesity is likely to be one of the risk factors affecting the condition. one.
衛部菌疫輸字第001140號
點擊圖片進入文章
注意事項與禁忌症
1.請勿將藥劑冷凍,經冷凍退冰後的善纖達也不應使用。
2.懷孕或哺乳、預備懷孕的婦女勿使用。
3.如果藥物或過敏及預備懷孕者請事先徵詢醫師意見。
4.甲狀腺、肝、腎、胰臟有疾病症狀之患者需遵照醫囑謹慎使用。
5.禁用於個人或是家族有甲狀腺髓質癌 (Medullary thyroid carcinoma, MTC)病史的病人,以及有第 2 型多發性內分泌腫瘤綜合症病人(Multiple Endocrine Neoplasia syndrome type 2, MEN 2)。
6.禁用於曾經對 liraglutide 過敏者。包括急性過敏性反應(anaphylactic reaction)及血管性水腫。
注意事項與禁忌症
1.請勿將藥劑冷凍,經冷凍退冰後的善纖達也不應使用。
2.懷孕或哺乳、預備懷孕的婦女勿使用。
3.如果藥物或過敏及預備懷孕者請事先徵詢醫師意見。
4.甲狀腺、肝、腎、胰臟有疾病症狀之患者需遵照醫囑謹慎使用。
5.禁用於個人或是家族有甲狀腺髓質癌 (Medullary thyroid carcinoma, MTC)病史的病人,以及有第 2 型多發性內分泌腫瘤綜合症病人(Multiple Endocrine Neoplasia syndrome type 2, MEN 2)。
6.禁用於曾經對 liraglutide 過敏者。包括急性過敏性反應(anaphylactic reaction)及血管性水腫。